Chromocell Therapeutics Corp
Chromocell Therapeutics Corp (CHRO) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 11 transactions totaling $125.8K, demonstrating a bullish sentiment with $125.8K in net insider flow. The most recent transaction on Sep 13, 2024 involved a purchase of 3,500 shares valued at $3.4K.
CHRO Insider Activity Summary
Who Is Buying CHRO Stock?
No significant insider buying has been recorded for CHRO in the recent period.
Who Is Selling CHRO Stock?
No significant insider selling has been recorded for CHRO in the recent period.
Is Chromocell Therapeutics Corp Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CHRO is bullish with an Insider Alignment Score of 100/100 and a net flow of $125.8K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CHRO Frequently Asked Questions
Understanding CHRO Insider Activity
Insider trading at Chromocell Therapeutics Corp (CHRO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading CHRO stock, having executed 11 transactions in the past 90 days. The most active insider is Ezra M. Friedberg (Executive), who has made 3 transactions totaling $199.1K.
Related Tools
Track Chromocell Therapeutics Corp Insider Activity
Get notified when executives and directors at CHRO file new Form 4 transactions